The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Effector T Helper Cell Subsets in Inflammatory Bowel Diseases
Open accessAbstract
The gastrointestinal tract is a site of high immune challenge, as it must maintain a delicate balance between tolerating luminal contents and generating an immune response towards pathogens. CD4+ T cells are key in mediating the host protective and homeostatic responses. Yet, CD4+ T cells are also known to be the main drivers of inflammatory bowel disease (IBD) when this balance is perturbed. Many subsets of CD4+ T cells have been identified as players in perpetuating chronic intestinal inflammation. Over the last few decades, understanding of how each subset of Th cells plays a role has dramatically increased. Simultaneously, this has allowed development of therapeutic innovation targeting specific molecules rather than broad immunosuppressive agents. Here, we review the emerging evidence of how each subset functions in promoting and sustaining the chronic inflammation that characterizes IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 14×
“Th2 (Chronic) IL-13, GATA3 Th9 (Acute) IL-9, PU.1 Th17 (Acute) IL-17R, SMAD7 Oxazolone Chemical Th2, NK-T IL-4, IL-13 (29, 31–35) Th9 IL-9, GATA3 Th17 TGF-β, SMAD7”
BackgroundInfluentialIvanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 1×
“The Th17 differentiation program is driven primarily by IL-6 and TGF-β (90) and further stabilized by signals from accessory cytokines including IL-23 and IL-1β (Figure 1) (91, 92).”
BackgroundTargan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced Macrophages
Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A., & Murphy, K. M. (1993) · Science · doi:10.1126/science.8097338 · Cited by 3,134
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Zelante, T., Iannitti, R. G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D’Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.003 · Cited by 2,614 · cited 1×
“Mechanistically, tryptophan metabolites can alter the intestinal microbiota in favor of microbes that induce AhR production and AhR-dependent IL-22 transcription (152).”
BackgroundGenome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Zheng, W.-P., & Flavell, R. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80240-8 · Cited by 2,384
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R., Modrusan, Z., Ghilardi, N., de Sauvage, F. J., et al. (2008) · Nature Medicine · doi:10.1038/nm1720 · Cited by 1,921
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Su, C., Sands, B. E., D’Haens, G. R., Vermeire, S., Schreiber, S., Danese, S., Feagan, B. G., Reinisch, W., Niezychowski, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606910 · Cited by 1,770
Non-Smad pathways in TGF-β signaling
Zhang, Y. E. (2009) · Cell Research · doi:10.1038/cr.2008.328 · Cited by 1,749
Hanauer, S. B., Sandborn, W. J., Rutgeerts, P., Fedorak, R. N., Lukas, M., MacIntosh, D., Panaccione, R., Wolf, D., & Pollack, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.030 · Cited by 1,715
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M. P., Maggi, E., Trinchieri, G., & Romagnani, S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1199 · Cited by 1,665
T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
Yang, X. O., Pappu, B. P., Nurieva, R., Akimzhanov, A., Kang, H. S., Chung, Y., Ma, L., Shah, B., Panopoulos, A. D., Schluns, K. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.016 · Cited by 1,605
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation
Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B., Meylan, F., Siegel, R., Hennighausen, L., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.009 · Cited by 1,507
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Wellcome Trust Case Control Consortium, & The Australo-Anglo-American Spondylitis Consortium (TASC) (2007) · Nature Genetics · doi:10.1038/ng.2007.17 · Cited by 1,374
Anderson, C. A., Boucher, G., Lees, C. W., Franke, A., D'Amato, M., Taylor, K. D., Lee, J. C., Goyette, P., Imielinski, M., Latiano, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.764 · Cited by 1,320
Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice
Kaplan, M. H., Sun, Y.-L., Hoey, T., & Grusby, M. J. (1996) · Nature · doi:10.1038/382174a0 · Cited by 1,240
Self-citationHELLER, F., FLORIAN, P., BOJARSKI, C., RICHTER, J., CHRIST, M., HILLENBRAND, B., MANKERTZ, J., GITTER, A., BURGEL, N., & FROMM, M. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.002 · Cited by 1,230
Fuss, I. J., Neurath, M., Boirivant, M., Klein, J. S., de la Motte, C., Strong, S. A., Fiocchi, C., & Strober, W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1261 · Cited by 1,227
Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., & Stockinger, B. (2008) · Nature Immunology · doi:10.1038/ni.1659 · Cited by 1,213
Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
Chung, Y., Chang, S. H., Martinez, G. J., Yang, X. O., Nurieva, R., Kang, H. S., Ma, L., Watowich, S. S., Jetten, A. M., Tian, Q., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.02.007 · Cited by 1,199
Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells
Thierfelder, W. E., van Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. R., Carson, R. T., Sangster, M. Y., Vignali, D. A. A., Doherty, P. C., Grosveld, G. C., et al. (1996) · Nature · doi:10.1038/382171a0 · Cited by 1,180
Powrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90045-0 · Cited by 1,146 · cited 1×
“(14), demonstrated that IFN-γ was not required for disease in this setting.”
BackgroundFantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., & Neurath, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5149 · Cited by 1,135
Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M., Strom, T. B., Elyaman, W., Ho, I.-C., et al. (2008) · Nature Immunology · doi:10.1038/ni.1677 · Cited by 1,122
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1767 · Cited by 1,079 · cited 2×
“Furthermore, while expression of the aryl hydrocarbon receptor (AhR) TFs is low in Th22 cells as compared to Th17 cells, it is also critical for IL-22 production from CD4 T cells (133, 136).”
BackgroundSTAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., Lehr, H.-A., Hirth, S., Weigmann, B., Wirtz, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082683 · Cited by 1,043
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A. K., Blumberg, R. S., Xavier, R. J., & Mizoguchi, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33194 · Cited by 1,023
Ishigame, H., Kakuta, S., Nagai, T., Kadoki, M., Nambu, A., Komiyama, Y., Fujikado, N., Tanahashi, Y., Akitsu, A., Kotaki, H., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.009 · Cited by 1,004 · cited 1×
“Citrobacter rodentium Infectious Th1 IFN- γ (37, 38)”
BackgroundEpithelial antimicrobial defence of the skin and intestine
Gallo, R. L., & Hooper, L. V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3228 · Cited by 957
Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System
Garrett, W. S., Lord, G. M., Punit, S., Lugo-Villarino, G., Mazmanian, S. K., Ito, S., Glickman, J. N., & Glimcher, L. H. (2007) · Cell · doi:10.1016/j.cell.2007.08.017 · Cited by 918
Interleukin-23 drives innate and T cell–mediated intestinal inflammation
Hue, S., Ahern, P., Buonocore, S., Kullberg, M. C., Cua, D. J., McKenzie, B. S., Powrie, F., & Maloy, K. J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061099 · Cited by 823
Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease
Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Stevens, S., & Flavell, R. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.11.003 · Cited by 800
Fuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19836 · Cited by 797
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
Lee, J. S., Tato, C. M., Joyce-Shaikh, B., Gulen, M. F., Cayatte, C., Chen, Y., Blumenschein, W. M., Judo, M., Ayanoglu, G., McClanahan, T. K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.003 · Cited by 760
A protective function for interleukin 17A in T cell–mediated intestinal inflammation
O'Connor Jr, W., Kamanaka, M., Booth, C. J., Town, T., Nakae, S., Iwakura, Y., Kolls, J. K., & Flavell, R. A. (2009) · Nature Immunology · doi:10.1038/ni.1736 · Cited by 756
Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and Homeostasis
Durant, L., Watford, W. T., Ramos, H. L., Laurence, A., Vahedi, G., Wei, L., Takahashi, H., Sun, H.-W., Kanno, Y., Powrie, F., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.003 · Cited by 726
IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
Huber, S., Gagliani, N., Zenewicz, L. A., Huber, F. J., Bosurgi, L., Hu, B., Hedl, M., Zhang, W., O’Connor, W., Murphy, A. J., et al. (2012) · Nature · doi:10.1038/nature11535 · Cited by 719
Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice
Mombaerts, P., Mizoguchi, E., Grusby, M. J., Glimcher, L. H., Bhan, A. K., & Tonegawa, S. (1993) · Cell · doi:10.1016/0092-8674(93)80069-q · Cited by 718
Stat6-Independent GATA-3 Autoactivation Directs IL-4-Independent Th2 Development and Commitment
Ouyang, W., Löhning, M., Gao, Z., Assenmacher, M., Ranganath, S., Radbruch, A., & Murphy, K. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)80156-9 · Cited by 702
Th17 Cell Differentiation: The Long and Winding Road
McGeachy, M. J., & Cua, D. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.001 · Cited by 701
The development of inflammatory TH-17 cells requires interferon-regulatory factor 4
Brüstle, A., Heink, S., Huber, M., Rosenplänter, C., Stadelmann, C., Yu, P., Arpaia, E., Mak, T. W., Kamradt, T., & Lohoff, M. (2007) · Nature Immunology · doi:10.1038/ni1500 · Cited by 692
Differential Activity of IL-12 and IL-23 in Mucosal and Systemic Innate Immune Pathology
Uhlig, H. H., McKenzie, B. S., Hue, S., Thompson, C., Joyce-Shaikh, B., Stepankova, R., Robinson, N., Buonocore, S., Tlaskalova-Hogenova, H., Cua, D. J., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.05.017 · Cited by 682
Monteleone, I., Rizzo, A., Sarra, M., Sica, G., Sileri, P., Biancone, L., MacDonald, T. T., Pallone, F., & Monteleone, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.007 · Cited by 656
Heller, F., Fuss, I. J., Nieuwenhuis, E. E., Blumberg, R. S., & Strober, W. (2002) · Immunity · doi:10.1016/s1074-7613(02)00453-3 · Cited by 650
TH2 cell development and function
Walker, J. A., & McKenzie, A. N. J. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.118 · Cited by 632
Neurath, M. F., Weigmann, B., Finotto, S., Glickman, J., Nieuwenhuis, E., Iijima, H., Mizoguchi, A., Mizoguchi, E., Mudter, J., Galle, P. R., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011956 · Cited by 607
Kamada, N., Hisamatsu, T., Okamoto, S., Chinen, H., Kobayashi, T., Sato, T., Sakuraba, A., Kitazume, M. T., Sugita, A., Koganei, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34610 · Cited by 603
Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease
Monteleone, G., Kumberova, A., Croft, N. M., McKenzie, C., Steer, H. W., & MacDonald, T. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12821 · Cited by 600
Hanash, A. M., Dudakov, J. A., Hua, G., O’Connor, M. H., Young, L. F., Singer, N. V., West, M. L., Jenq, R. R., Holland, A. M., Kappel, L. W., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.028 · Cited by 584
Rutgeerts, P., Van Assche, G., Sandborn, W. J., Wolf, D. C., Geboes, K., Colombel, J., Reinisch, W., Kumar, A., Lazar, A., Camez, A., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.035 · Cited by 580
Chang, H.-C., Sehra, S., Goswami, R., Yao, W., Yu, Q., Stritesky, G. L., Jabeen, R., McKinley, C., Ahyi, A.-N., Han, L., et al. (2010) · Nature Immunology · doi:10.1038/ni.1867 · Cited by 577
Self-citationLemaitre, M., Kirchgesner, J., Rudnichi, A., Carrat, F., Zureik, M., Carbonnel, F., & Dray-Spira, R. (2017) · JAMA · doi:10.1001/jama.2017.16071 · Cited by 575
Stat3 and Stat4 Direct Development of IL-17-Secreting Th Cells
Mathur, A. N., Chang, H.-C., Zisoulis, D. G., Stritesky, G. L., Yu, Q., O’Malley, J. T., Kapur, R., Levy, D. E., Kansas, G. S., & Kaplan, M. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4901 · Cited by 555
Self-citationInterferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells
Staudt, V., Bothur, E., Klein, M., Lingnau, K., Reuter, S., Grebe, N., Gerlitzki, B., Hoffmann, M., Ulges, A., Taube, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.07.014 · Cited by 554
Rutgeerts, P., Diamond, R. H., Bala, M., Olson, A., Lichtenstein, G. R., Bao, W., Patel, K., Wolf, D. C., Safdi, M., Colombel, J. F., et al. (2006) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2005.08.011 · Cited by 548
In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells
Lochner, M., Peduto, L., Cherrier, M., Sawa, S., Langa, F., Varona, R., Riethmacher, D., Si-Tahar, M., Di Santo, J. P., & Eberl, G. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080034 · Cited by 542
Boirivant, M., Fuss, I. J., Chu, A., & Strober, W. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1929 · Cited by 529
Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells
Ahern, P. P., Schiering, C., Buonocore, S., McGeachy, M. J., Cua, D. J., Maloy, K. J., & Powrie, F. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.010 · Cited by 528
van der Valk, M. E., Mangen, M.-J. J., Leenders, M., Dijkstra, G., van Bodegraven, A. A., Fidder, H. H., de Jong, D. J., Pierik, M., van der Woude, C. J., Romberg-Camps, M. J. L., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-303376 · Cited by 500
c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont
Xu, M., Pokrovskii, M., Ding, Y., Yi, R., Au, C., Harrison, O. J., Galan, C., Belkaid, Y., Bonneau, R., & Littman, D. R. (2018) · Nature · doi:10.1038/nature25500 · Cited by 498
Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice
Ogawa, A., Andoh, A., Araki, Y., Bamba, T., & Fujiyama, Y. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.09.013 · Cited by 495
Andoh, A., Zhang, Z., Inatomi, O., Fujino, S., Deguchi, Y., Araki, Y., Tsujikawa, T., Kitoh, K., Kim–Mitsuyama, S., Takayanagi, A., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.071 · Cited by 481
Control of T Helper 2 Responses by Transcription Factor IRF4-Dependent Dendritic Cells
Gao, Y., Nish, S. A., Jiang, R., Hou, L., Licona-Limón, P., Weinstein, J. S., Zhao, H., & Medzhitov, R. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.028 · Cited by 478
Critical role of IL-17 receptor signaling in acute TNBS-induced colitis
Zhang, Z., Zheng, M., Bindas, J., Schwarzenberger, P., & Kolls, J. K. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000218764.06959.91 · Cited by 465
The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin
Weaver, C. T., Elson, C. O., Fouser, L. A., & Kolls, J. K. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130318 · Cited by 462
Th22 Cells Are an Important Source of IL-22 for Host Protection against Enteropathogenic Bacteria
Basu, R., O’Quinn, D. B., Silberger, D. J., Schoeb, T. R., Fouser, L., Ouyang, W., Hatton, R. D., & Weaver, C. T. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.024 · Cited by 454
Monoclonal Anti–Interleukin 23 Reverses Active Colitis in a T Cell–Mediated Model in Mice
Elson, C. O., Cong, Y., Weaver, C. T., Schoeb, T. R., McClanahan, T. K., Fick, R. B., & Kastelein, R. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.104 · Cited by 453 · cited 1×
“These findings were confirmed in similar models where either IL-23Rdeficient donor cells (115) were transferred or IL-23 signaling was blocked with neutralizing antibodies (116).”
ResultFeagan, B. G., Sandborn, W. J., D'Haens, G., Panés, J., Kaser, A., Ferrante, M., Louis, E., Franchimont, D., Dewit, O., Seidler, U., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30570-6 · Cited by 451
Leppkes, M., Becker, C., Ivanov, I. I., Hirth, S., Wirtz, S., Neufert, C., Pouly, S., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.018 · Cited by 444
the Wellcome Trust Case Control Consortium, Fisher, S. A., Tremelling, M., Anderson, C. A., Gwilliam, R., Bumpstead, S., Prescott, N. J., Nimmo, E. R., Massey, D., Berzuini, C., et al. (2008) · Nature Genetics · doi:10.1038/ng.145 · Cited by 424
IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage
Stritesky, G. L., Yeh, N., & Kaplan, M. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5948 · Cited by 417
Self-citationGerlach, K., Hwang, Y., Nikolaev, A., Atreya, R., Dornhoff, H., Steiner, S., Lehr, H.-A., Wirtz, S., Vieth, M., Waisman, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2920 · Cited by 407
Identification of the Functional Interleukin-22 (IL-22) Receptor Complex
Kotenko, S. V., Izotova, L. S., Mirochnitchenko, O. V., Esterova, E., Dickensheets, H., Donnelly, R. P., & Pestka, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007837200 · Cited by 400
Ulcerative colitis–risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study
Silverberg, M. S., Cho, J. H., Rioux, J. D., McGovern, D. P. B., Wu, J., Annese, V., Achkar, J.-P., Goyette, P., Scott, R., Xu, W., et al. (2009) · Nature Genetics · doi:10.1038/ng.275 · Cited by 396
Niessner, M., & Volk, B. A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03130.x · Cited by 388
Targan, S. R., Feagan, B., Vermeire, S., Panaccione, R., Melmed, G. Y., Landers, C., Li, D., Russell, C., Newmark, R., Zhang, N., et al. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.298 · Cited by 383
The Transcription Factor c-Maf Controls the Production of Interleukin-4 but Not Other Th2 Cytokines
Kim, J. I., Ho, I.-C., Grusby, M. J., & Glimcher, L. H. (1999) · Immunity · doi:10.1016/s1074-7613(00)80073-4 · Cited by 382
Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice
Ito, R., Shin-Ya, M., Kishida, T., Urano, A., Takada, R., Sakagami, J., Imanishi, J., Kita, M., Ueda, Y., Iwakura, Y., et al. (2006) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03214.x · Cited by 364
Liu, Z., Lee, J., Krummey, S., Lu, W., Cai, H., & Lenardo, M. J. (2011) · Nature Immunology · doi:10.1038/ni.2113 · Cited by 361
Franke, A., Balschun, T., Karlsen, T. H., Hedderich, J., May, S., Lu, T., Schuldt, D., Nikolaus, S., Rosenstiel, P., Krawczak, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.148 · Cited by 352
Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation
Maxwell, J. R., Zhang, Y., Brown, W. A., Smith, C. L., Byrne, F. R., Fiorino, M., Stevens, E., Bigler, J., Davis, J. A., Rottman, J. B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.019 · Cited by 342
Nava, P., Koch, S., Laukoetter, M. G., Lee, W. Y., Kolegraff, K., Capaldo, C. T., Beeman, N., Addis, C., Gerner-Smidt, K., Neumaier, I., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.001 · Cited by 337
Powell, N., Walker, A. W., Stolarczyk, E., Canavan, J. B., Gökmen, M. R., Marks, E., Jackson, I., Hashim, A., Curtis, M. A., Jenner, R. G., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.008 · Cited by 324
Wei, L., Vahedi, G., Sun, H.-W., Watford, W. T., Takatori, H., Ramos, H. L., Takahashi, H., Liang, J., Gutierrez-Cruz, G., Zang, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.003 · Cited by 322
Interleukin-23/Th17 pathways and inflammatory bowel disease
Abraham, C., & Cho, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20894 · Cited by 289
Simpson, S. J., Shah, S., Comiskey, M., de Jong, Y. P., Wang, B., Mizoguchi, E., Bhan, A. K., & Terhorst, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1225 · Cited by 278
The Jak-Stat Pathway: Cytokine Signalling from the Receptor to the Nucleus
Heim, M. H. (1999) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899909036638 · Cited by 271
Wolk, K., Witte, E., Hoffmann, U., Doecke, W.-D., Endesfelder, S., Asadullah, K., Sterry, W., Volk, H.-D., Wittig, B. M., & Sabat, R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5973 · Cited by 270
Growth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage
Song, X., Dai, D., He, X., Zhu, S., Yao, Y., Gao, H., Wang, J., Qu, F., Qiu, J., Wang, H., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.024 · Cited by 243
Withers, D. R., Hepworth, M. R., Wang, X., Mackley, E. C., Halford, E. E., Dutton, E. E., Marriott, C. L., Brucklacher-Waldert, V., Veldhoen, M., Kelsen, J., et al. (2016) · Nature Medicine · doi:10.1038/nm.4046 · Cited by 243
Identification of Natural RORγ Ligands that Regulate the Development of Lymphoid Cells
Santori, F. R., Huang, P., van de Pavert, S. A., Douglass, E. F., Leaver, D. J., Haubrich, B. A., Keber, R., Lorbek, G., Konijn, T., Rosales, B. N., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.004 · Cited by 235
Thieu, V. T., Yu, Q., Chang, H.-C., Yeh, N., Nguyen, E. T., Sehra, S., & Kaplan, M. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.017 · Cited by 231
Self-citationTh1/Th17 Immune Response Is Induced by Mesenteric Lymph Node Dendritic Cells in Crohn's Disease
Sakuraba, A., Sato, T., Kamada, N., Kitazume, M., Sugita, A., & Hibi, T. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.049 · Cited by 230
Mudter, J., Weigmann, B., Bartsch, B., Kiesslich, R., Strand, D., Galle, P. R., Lehr, H. A., Schmidt, J., & Neurath, M. F. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40615.x · Cited by 230
Cutting Edge: IL-23 Cross-Regulates IL-12 Production in T Cell-Dependent Experimental Colitis
Becker, C., Dornhoff, H., Neufert, C., Fantini, M. C., Wirtz, S., Huebner, S., Nikolaev, A., Lehr, H.-A., Murphy, A. J., Valenzuela, D. M., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2760 · Cited by 227
Th9 cell development requires a BATF-regulated transcriptional network
Jabeen, R., Goswami, R., Awe, O., Kulkarni, A., Nguyen, E. T., Attenasio, A., Walsh, D., Olson, M. R., Kim, M. H., Tepper, R. S., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69489 · Cited by 225
Self-citationFichtner-Feigl, S., Fuss, I. J., Young, C. A., Watanabe, T., Geissler, E. K., Schlitt, H.-J., Kitani, A., & Strober, W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5859 · Cited by 199
Constitutive STAT3 Activation in Intestinal T Cells from Patients with Crohn's Disease
Lovato, P., Brender, C., Agnholt, J., Kelsen, J., Kaltoft, K., Svejgaard, A., Eriksen, K. W., Woetmann, A., & Ødum, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207999200 · Cited by 199
Tolerogenic nanoparticles inhibit T cell–mediated autoimmunity through SOCS2
Yeste, A., Takenaka, M. C., Mascanfroni, I. D., Nadeau, M., Kenison, J. E., Patel, B., Tukpah, A.-M., Babon, J. A. B., DeNicola, M., Kent, S. C., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aad0612 · Cited by 199
Boirivant, M., Pallone, F., Di Giacinto, C., Fina, D., Monteleone, I., Marinaro, M., Caruso, R., Colantoni, A., Palmieri, G., Sanchez, M., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.016 · Cited by 197
STAT4: A Critical Regulator of Inflammation In Vivo
Kaplan, M. H. (2005) · Immunologic Research · doi:10.1385/ir:31:3:231 · Cited by 192
Self-citationWirtz, S. J., Finotto, S., Kanzler, S., Lohse, A. W., Blessing, M., Lehr, H. A., Galle, P. R., & Neurath, M. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.1884 · Cited by 192
Role of SMAD and Non-SMAD Signals in the Development of Th17 and Regulatory T Cells
Lu, L., Wang, J., Zhang, F., Chai, Y., Brand, D., Wang, X., Horwitz, D. A., Shi, W., & Zheng, S. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903418 · Cited by 191
Anderson, C. A., Massey, D. C. O., Barrett, J. C., Prescott, N. J., Tremelling, M., Fisher, S. A., Gwilliam, R., Jacob, J., Nimmo, E. R., Drummond, H., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.032 · Cited by 185
IL-9 and its receptor are predominantly involved in the pathogenesis of UC
Nalleweg, N., Chiriac, M. T., Podstawa, E., Lehmann, C., Rau, T. T., Atreya, R., Krauss, E., Hundorfean, G., Fichtner-Feigl, S., Hartmann, A., et al. (2015) · Gut · doi:10.1136/gutjnl-2013-305947 · Cited by 181
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression
Fantini, M. C., Rizzo, A., Fina, D., Caruso, R., Sarra, M., Stolfi, C., Becker, C., MacDonald, T. T., Pallone, F., Neurath, M. F., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.053 · Cited by 179
Wirtz, S. J., Finotto, S., Kanzler, S., Lohse, A. W., Blessing, M., Lehr, H. A., Galle, P. R., & Neurath, M. F. (1999) · PubMed · Cited by 179
Danese, S., Rudziński, J., Brandt, W., Dupas, J., Peyrin‐Biroulet, L., Bouhnik, Y., Kleczkowski, D., Uebel, P., Lukáš, M., Knutsson, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-308004 · Cited by 170
Understanding inflammatory bowel disease via immunogenetics
de Lange, K. M., & Barrett, J. C. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.013 · Cited by 166
Reinisch, W., Panés, J., Khurana, S., Toth, G., Hua, F., Comer, G. M., Hinz, M., Page, K. M., O’Toole, M., Moorehead, T. M., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308337 · Cited by 163
Martin, J. P. D., Bériou, G., Heslan, M., Chauvin, C., Utriainen, L., Aumeunier, A., Scott, C. L., Mowat, A. M., Cerovic, V., Houston, S. A., et al. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.28 · Cited by 162
Fichtner–Feigl, S., Young, C. A., Kitani, A., Geissler, E. K., Schlitt, H., & Strober, W. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.055 · Cited by 158
A pathogenic role for T cell–derived IL-22BP in inflammatory bowel disease
Pelczar, P., Witkowski, M., Pérez, L. G., Kempski, J., Hammel, A., Brockmann, L., Kleinschmidt, D., Wende, S., Haueis, C., Bedke, T., et al. (2016) · Science · doi:10.1126/science.aah5903 · Cited by 146
Crohn’s Disease and Ulcerative Colitis Show Unique Cytokine Profiles
Németh, Z. H., Bogdanovski, D. A., Stopper, P. B., Paglinco, S. R., Antonioli, L., & Rolandelli, R. H. (2017) · Cureus · doi:10.7759/cureus.1177 · Cited by 145
Tanaka, S., Suto, A., Iwamoto, T., Kashiwakuma, D., Kagami, S., Suzuki, K., Takatori, H., Tamachi, T., Hirose, K., Onodera, A., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20130791 · Cited by 144
Muzaki, A. R. B. M., Tetlak, P., Sheng, J., Loh, S.-C., Setiagani, Y. A., Poidinger, M., Zolezzi, F., Karjalainen, K., & Ruedl, C. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.64 · Cited by 141
Role of TNF receptors, TNFR1 and TNFR2, in dextran sodium sulfate-induced colitis
Stillie, R., & Stadnyk, A. W. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20951 · Cited by 138
Mudter, J., Amoussina, L., Schenk, M., Yu, J., Brüstle, A., Weigmann, B., Atreya, R. N., Wirtz, S. J., Becker, C., Hoffman, A. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33227 · Cited by 134
Plank, M. W., Kaiko, G. E., Maltby, S., Weaver, J., Tay, H. L., Shen, W., Wilson, M. S., Durum, S. K., & Foster, P. S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601480 · Cited by 130
Camelo, A., Barlow, J. L., Drynan, L. F., Neill, D. R., Ballantyne, S. J., Wong, S. H., Pannell, R., Gao, W., Wrigley, K., Sprenkle, J., et al. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0591-2 · Cited by 128
Mizoguchi, A., Mizoguchi, E., & Bhan, A. K. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70128-9 · Cited by 128
van Unen, V., Li, N., Molendijk, I., Temurhan, M., Höllt, T., Jong, A. E. V. D. M., Verspaget, H. W., Mearin, M. L., Mulder, C. J. J., van Bergen, J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.014 · Cited by 128
The role of IL-13 and NK T cells in experimental and human ulcerative colitis
Fuss, I. J., & Strober, W. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.40 · Cited by 126
Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells
Abe, K., Nguyen, K., Fine, S., Mo, J., Shen, C., Shenouda, S., Corr, M., Jung, S., Lee, J., Eckmann, L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708469104 · Cited by 125
Rosen, M. J., Frey, M. R., Washington, K. M., Chaturvedi, R., Kuhnhein, L. A., Matta, P., Revetta, F. L., Wilson, K. T., & Polk, D. B. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21628 · Cited by 119
Roberts, R. L., Gearry, R. B., Hollis‐Moffatt, J. E., Miller, A. L., Reid, J., Abkevich, V., Timms, K. M., Gutin, A., Lanchbury, J. S. S., Merriman, T. R., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01525.x · Cited by 118
IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo
Mudter, J., Yu, J., Zufferey, C., Brüstle, A., Wirtz, S. J., Weigmann, B., Hoffman, A. W., Schenk, M., Galle, P. R., Lehr, H. A., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21476 · Cited by 116
Reversing SKI–SMAD4-mediated suppression is essential for TH17 cell differentiation
Zhang, S., Takaku, M., Zou, L., Gu, A.-D., Chou, W.-C., Zhang, G., Wu, B., Kong, Q., Thomas, S. Y., Serody, J. S., et al. (2017) · Nature · doi:10.1038/nature24283 · Cited by 116
The transcription factor NFATc2 controls IL-6–dependent T cell activation in experimental colitis
Weigmann, B., Lehr, H. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Stevens, S. G., Schmidt, J., Galle, P. R., Rose‐John, S., & Neurath, M. F. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072484 · Cited by 110
Smad2 Positively Regulates the Generation of Th17 Cells*
Martínez, G., Zhang, Z., Reynolds, J. M., Tanaka, S., Chung, Y., Liu, T., Robertson, E. J., Lin, X., Feng, X., & Dong, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.155820 · Cited by 109
CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study.
Stronkhorst, A., Radema, S. A., Yong, S. L., Bijl, H. M., ten Berge, I. J. M., Tytgat, G. N. J., & van Deventer, S. J. H. (1997) · Gut · doi:10.1136/gut.40.3.320 · Cited by 107
Gcn5 Is Required for PU.1-Dependent IL-9 Induction in Th9 Cells
Goswami, R., & Kaplan, M. H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201496 · Cited by 100 · cited 1×
“1 binds to the Il9 promoter and alters histone acetylation (192).”
BackgroundSelf-citationLi, J., Ueno, A., Gasia, M. F., Luider, J. M., Wang, T., Hirota, C. L., Jijon, H. B., Deane, M., Tom, M. R., Chan, R., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000811 · Cited by 99
Cummings, F. J. R., Ahmad, T., Geremia, A., Beckly, J. B., Cooney, R. M., Hancock, L., Pathan, S., Guo, C., Cardon, L. R., & Jewell, D. P. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20180 · Cited by 97
T-bet is a key modulator of IL-23-driven pathogenic CD4+ T cell responses in the intestine
Krausgruber, T., Schiering, C., Adelmann, K., Harrison, O. J., Chomka, A., Pearson, C. F., Ahern, P. P., Shale, M., Oukka, M., & Powrie, F. M. (2016) · Nature Communications · doi:10.1038/ncomms11627 · Cited by 96
Rosen, M. J., Chaturvedi, R., Washington, M. K., Kuhnhein, L. A., Moore, P. D., Coggeshall, S. S., McDonough, E. M., Weitkamp, J.-H., Singh, A. B., Coburn, L. A., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201373 · Cited by 95
TH17 Cell Induction and Effects of IL-17A and IL-17F Blockade in Experimental Colitis
Schmidt, E. G. W., Larsen, H. L., Kristensen, N. N., Poulsen, S. S., Pedersen, A. M. L., Claësson, M. H., & Pedersen, A. E. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318286fa1c · Cited by 95
Backert, I., Koralov, S. B., Wirtz, S. J., Kitowski, V., Billmeier, U., Martini, E., Hofmann, K., Hildner, K., Wittkopf, N., Brecht, K., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303076 · Cited by 94
Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody
Emmrich, J., Seyfarth, M., Fleig, W. E., & Emmrich, F. (1991) · The Lancet · doi:10.1016/0140-6736(91)91133-f · Cited by 92
Aychek, T., Mildner, A., Yona, S., Kim, K.-W., Lampl, N., Reich-Zeliger, S., Boon, L., Yogev, N., Waisman, A., Cua, D. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms7525 · Cited by 90
JAK inhibition in inflammatory bowel disease
Olivera, P. A., Danese, S., & Peyrin‐Biroulet, L. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1291342 · Cited by 89
Shah, E. D., Farida, J. P., Siegel, C. A., Chong, K., & Melmed, G. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001049 · Cited by 89
The transcription factor network in Th9 cells
Kaplan, M. H. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0600-2 · Cited by 88
Self-citationTGF-β is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23
Morishima, N., Mizoguchi, I., Takeda, K., Mizuguchi, J., & Yoshimoto, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.140 · Cited by 87
Popp, V., Gerlach, K., Mott, S., Turowska, A. M., Garn, H., Atreya, R. N., Lehr, H., Ho, I., Renz, H., Weigmann, B., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.09.005 · Cited by 87
IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis
Gerlach, K., McKenzie, A. N., Neurath, M. F., & Weigmann, B. (2015) · Tissue Barriers · doi:10.4161/21688370.2014.983777 · Cited by 83
SMAD2 Is Essential for TGFβ-mediated Th17 Cell Generation*
Malhotra, N., Robertson, E. J., & Kang, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.156745 · Cited by 82
IL-5 and TNF-α Participate in Recruitment of Eosinophils to Intestinal Mucosa in Ulcerative Colitis
Lampinen, M., Carlson, M., Sangfelt, P., et al. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1010659803912 · Cited by 81
IL-22BP dictates characteristics of Peyer’s patch follicle-associated epithelium for antigen uptake
Jinnohara, T., Kanaya, T., Hase, K., Sakakibara, S., Kato, T., Tachibana, N., Sasaki, T., Hashimoto, Y., Sato, T., Watarai, H., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160770 · Cited by 81
Good, S. R., Thieu, V. T., Mathur, A. N., Yu, Q., Stritesky, G. L., Yeh, N., O’Malley, J. T., Perumal, N. B., & Kaplan, M. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901411 · Cited by 75
Self-citationSTAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility
Cénit, M. C., Alcina, A., Márquez, A., Mendoza, J. L., Diaz-Rubio, M. E., Heras, V. D. L., Izquierdo, G., Arroyo, R., Fernández, Ó., de la Concha, E. G., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.10 · Cited by 71
Replication of an Association Between IL23R Gene Polymorphism With Inflammatory Bowel Disease
Oliver, J., Rueda‐Medina, B., López‐Nevot, M. Á., Gómez–García, M., & Martin, J. J. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.002 · Cited by 69
Analysis of IL12B Gene Variants in Inflammatory Bowel Disease
Glas, J., Seiderer, J., Wagner, J. E., Olszak, T., Fries, C., Tillack, C., Friedrich, M., Beigel, F., Stallhofer, J., Steib, C. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034349 · Cited by 61
Lakatos, P. L., Szamosi, T., Szilvási, A., Molnar, E., Lakatos, P. L., Kovacs, A., Molnar, T., Altorjay, I. F., Papp, M., Tulassay, Z., et al. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.03.022 · Cited by 61
Different regulation of eosinophil activity in Crohn’s disease compared with ulcerative colitis
Lampinen, M., Backman, M., Winqvist, O., Rorsman, F., Rönnblom, A., Sangfelt, P., & Carlson, M. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0807513 · Cited by 58
NOD2/CARD15 and TNFA, But Not ILLB and ILLRN, are Associated With Crohnʼs Disease
Ferreira, A. C., Almeida, S. S., Tavares, M., Canedo, P., Pereira, F., Regalo, G., Figueiredo, C., Trindade, E., Seruca, R., Carneiro, F., et al. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000158153.71579.b4 · Cited by 56
Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis
Shen, C., Hertogh, G. D., Bullens, D. M. A., Assche, G. V., Geboes, K. J., Rutgeerts, P. J., & Ceuppens, J. L. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20005 · Cited by 55
IL-10 and TNF-α promoter haplotypes are associated with childhood Crohn’s disease location
Sánchez, R., Levy, E. H., Costea, F., & Sinnett, D. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.3776 · Cited by 50
Mo, C., Chearwae, W., O’Malley, J. T., Adams, S. M., Kanakasabai, S., Walline, C. C., Stritesky, G. L., Good, S. R., Perumal, N. B., Kaplan, M. H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5681 · Cited by 49
Self-citationGonsky, R., Deem, R. L., Landers, C. J., Haritunians, T., Yang, S., & Targan, S. R. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000172 · Cited by 48
Genetic variants alter T-bet binding and gene expression in mucosal inflammatory disease
Soderquest, K., Hertweck, A., Giambartolomei, C., Henderson, S. R., Mohamed, R., Goldberg, R., Perucha, E., Franke, L., Herrero, J., Plagnol, V., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006587 · Cited by 47
IL-17/IFN-γ Interactions Regulate Intestinal Inflammation in TNBS-Induced Acute Colitis
Jin, Y., Lin, Y., Lin, L., & Zheng, C.-Q. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0030 · Cited by 46
Differential Role of Tumor Necrosis Factor Receptors in TNBS Colitis
Ebach, D. R., Newberry, R. D., & Stenson, W. F. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000163698.34592.30 · Cited by 45
IL23R and IL12B polymorphisms in spanish IBD patients: No evidence of interaction
Márquez, A., Mendoza, J. L., Taxonera, C., Díaz‐Rubio, M., de la Concha, E. G., Urcelay, E., & Martínez, A. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20463 · Cited by 45
López‐Hernández, R., Valdés, M., Campillo, J. A., Martínez‐Garcia, P., Salama, H., Salgado, G., Boix, F., Moya‐Quiles, M. R., Minguela, A., Sánchez‐Torres, A., et al. (2013) · International Journal of Immunogenetics · doi:10.1111/iji.12059 · Cited by 41
IL-9 antibody injection suppresses the inflammation in colitis mice
Yuan, A., Yang, H., Qi, H., Cui, J., Wei, H., Li, C., Pang, Z., Zheng, W., & Cui, G. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.057 · Cited by 41
Significance of serum Il-9 levels in inflammatory bowel disease
Defendenti, C., Sarzi‐Puttini, P., Saibeni, S., Bollani, S., Bruno, S., Almasio, P. L., Declich, P., & Atzeni, F. (2015) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632015600535 · Cited by 40
Zhang, J., Wu, J., Peng, X., Song, J., Wang, J., & Dong, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109625 · Cited by 37
O’Malley, J. T., Eri, R. D., Stritesky, G. L., Mathur, A. N., Chang, H., HogenEsch, H., Srinivasan, M., & Kaplan, M. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.5062 · Cited by 37
Self-citationWang, Y., Han, G., Chen, Y., Wang, K., Liu, G., Wang, R., He, X., Li, X., Hou, C., Shen, B., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.89 · Cited by 36
Matusiewicz, M., Neubauer, K., Bednarz‐Misa, I., Górska, S., & Krzystek‐Korpacka, M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i22.4039 · Cited by 36
Overexpression of GATA-3 in T Cells Accelerates Dextran Sulfate Sodium-Induced Colitis
Okamura, M., Yoh, K., Ojima, M., Morito, N., & Takahashi, S. (2014) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.63.133 · Cited by 32
Cotterill, L., Payne, D., Levison, S., McLaughlin, J. T., Wesley, E., Feeney, M., Durbin, H., Lal, S., Makin, A. J., Campbell, S. S., et al. (2009) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2010/480458 · Cited by 29
DSS-Induced Colitis Is Exacerbated in STAT-6 Knockout Mice
Elrod, J. W., Laroux, S., Houghton, J. F., Carpenter, A. C., Ando, T., Jennings, M. H., Grisham, M. B., Walker, N., & Alexander, S. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000182871.76434.57 · Cited by 28
Díaz-Gallo, L.-M., Palomino‐Morales, R., Gómez–García, M., Cardeña, C., Rodrigo, L., Nieto, A., Alcaín, G., Cueto, I., López‐Nevot, M. Á., & Martin, J. J. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.02.005 · Cited by 28
Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease
Daryani, N. E., Saghazadeh, A., Moossavi, S., Sadr, M., Shahkarami, S., Soltani, S., Farhadi, E., & Rezaei, N. (2017) · Immunological Investigations · doi:10.1080/08820139.2017.1360343 · Cited by 28
Gaffen, S. L. (2015) · Nature reviews. Immunology · doi:10.1038/nri.2015.2 · Cited by 26
Okuda, Y., Takahashi, I., Kim, J., Ohta, N., Iwatani, K., Iijima, H., Kai, Y., Tamagawa, H., Hiroi, T., Kweon, M., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63817-5 · Cited by 16
Naderi, N., Farnood, A., Dadaei, T., Habibi, M., Balaii, H., Firouzi, F., Mahban, A., Soltani, M., & Zali, M. R. (2014) · PubMed Central · Cited by 16
Moon, C. M., Shin, D., Son, N., Shin, E., Hong, S. P., Kim, T. I., Kim, W. H., & Cheon, J. H. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12214 · Cited by 15
Altered STAT4 Isoform Expression in Patients with Inflammatory Bowel Disease
Jabeen, R., Miller, L., Yao, W., Gupta, S. K., Steiner, S. J., & Kaplan, M. H. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000495 · Cited by 13
Self-citationYang, Y., Wang, H., Dou, Y., Wang, Y., Han, G., Wang, R., Wang, L., Guo, R., He, X., Li, X., et al. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04413.x · Cited by 11
Weigmann, B., Nemetz, A., Becker, C., Schmidt, J., Strand, D. J., Lehr, H. A., Galle, P. R., Ho, I., & Neurath, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3446 · Cited by 11
Zhu, H., Liu, J., Zhang, H., Wang, Z., Liu, J., Lu, S., Xu, W., Zhong, J., & Wang, Z. (2013) · Biomedical Reports · doi:10.3892/br.2013.59 · Cited by 5
Cited by
Zhang, M. J., Hou, K., Dey, K. K., Sakaue, S., Jagadeesh, K. A., Weinand, K., Taychameekiatchai, A., Rao, P., Pisco, A. O., Zou, J., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01167-z · Cited by 302
Distinct microbial and immune niches of the human colon
James, K. R., Gomes, T., Elmentaite, R., Kumar, N., Gulliver, E. L., King, H. W., Stares, M. D., Bareham, B. R., Ferdinand, J. R., Petrova, V. N., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0602-z · Cited by 294
Big data in IBD: big progress for clinical practice
Seyed Tabib, N. S., Madgwick, M., Sudhakar, P., Verstockt, B., Korcsmaros, T., & Vermeire, S. (2020) · Gut · doi:10.1136/gutjnl-2019-320065 · Cited by 223
Sudhakar, P., Verstockt, B., Cremer, J., Verstockt, S., Sabino, J., Ferrante, M., & Vermeire, S. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa281 · Cited by 49
Merk, V. M., Phan, T. S., & Brunner, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.672808 · Cited by 27
Metadata
- Authors
- Imam, T., Park, S., Kaplan, M. H., & Olson, M. R.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-06-01
- Volume
- 9
- Pages
- 1212-1212
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2806315338
- Cited by
- 267
- References
- 194
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.